RELATED STUDY
Cannabidiol and Neurodevelopmental Disorders in Children
Key Findings: There is strong evidence that treatment with cannabinoids, specifically cannabidiol, is safe and well-tolerated for many of the common symptoms affecting children with neurodevelopmental disorders.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Australia, Italy
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD), Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Cannabinoid (unspecified), Microbiome
Phytocannabinoid Source: Unspecified
Chemotype: Chemotype III
Receptors Studied: CB1, CB2, GPCR 55, TRPV1, TRPV2, PPAR - Alpha
Ligands Studied: Acetylcholine, Anti-inflammatory cytokines, Dopamine, GABA, Glutamate, Serotonin, Pro-inflammatory cytokines
Citation: Kwan Cheung KA, et al. Cannabidiol and Neurodevelopmental Disorders in Children. Front Psychiatry. 2021; 12:643442. doi: 10.3389/fpsyt.2021.643442
Authors: Kwan Cheung KA, Mitchell MD, Heussler HS
